User fee inflation to slow in PDUFA VI

Industry and FDA have agreed to restructure PDUFA fees as part of the PDUFA VI agreement goals letter released Friday. The new structure is intended to make FDA funding more predictable, and is expected to slow the fees' rate of increase. As a result of changes in the way FDA’s workload and costs are measured, the annual increase in user fees is

Read the full 623 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers